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Introduction
Neural tube defects (NTDs) have an incidence of 1–2
per 1,000 births and are considered to be a heteroge-
neous condition resulting from failure of normal neu-
ral tube closure between the third and fourth week of
embryonic development. The three common types of
NTDs are anencephaly, spina bifida, and encephalo-
cele. The uncommon types of NTDs include amniotic
band syndrome, limb–body wall complex, cloacal ex-
strophy or OEIS (omphalocele-exstrophy-imperforate
anus-spinal defects) complex, and other types of spinal
abnormalities. The incidence of NTDs varies with race,
geographic variation, socioeconomic classes, nutritional
status, and multiple predisposing factors such as single
gene disorders (Meckel syndrome, median cleft face
syndrome, Roberts syndrome, Jarcho-Levin syndrome
and HARD [hydrocephalus, agyria, retinal dysplasia]
syndrome), chromosomal abnormalities (trisomy 18,
trisomy 13, triploidy and other structural abnormalities),
teratogens (valproic acid, aminopterin/amethopterin
and thalidomide), maternal diabetes, family history of
NTDs, thermolabile mutation in the MTHFR gene, and
others [1]. There is considerable evidence that genetics
contributes to the etiology of NTDs. Fetuses with NTDs
carry a risk of chromosomal abnormalities. The risk
varies with maternal age, gestational age at diagnosis,
association with other structural abnormalities, and
family history of chromosome aberrations.
Chromosomal Abnormalities Associated
with NTDs in Aborted Embryos
When the diagnosis of NTDs is made in aborted
embryos, the percentage of aneuploidy can increase to
over 70% [2–5]. Table 1 shows the reported incidence
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of chromosomal abnormalities associated with NTDs
in aborted embryos. Table 2 shows the characteristics
of aborted embryos with NTDs. Byrne and Warburton
[2] reported the incidence of 1.02% of NTDs in spon-
taneous abortions, a rate about 10 times higher than
in term births. In their study of 879 spontaneous fetal
losses occurring before 28 weeks’ gestation, six embryos
and three fetuses had NTDs. All of the six embryos had
chromosomal abnormalities. Triploidy occurred in two
embryos, one with anencephaly and spina bifida, and
the other with iniencephaly. One embryo had exenceph-
aly, cleft lip and palate, and trisomy 21 [t(21q;21q)].
Three embryos had encephaloceles, of which one had
mosaic trisomy 20, one had monosomy X, and one
with trisomy 13 [t(13q;13q)]. McFadden and Kalousek
[3] reported the incidence of 6.7% of NTDs in spon-
taneously aborted embryos, a rate markedly higher
than the 0.155% of NTDs in births observed in British
Columbia, Canada. In their study of 569 embryos at the
developmental age of less than 9 weeks, 38 embryos
had NTDs of which 32 had cytogenetic analysis. Of the
32 embryos, 26 (81.25%) were cytogenetically abnor-
mal. Of the two embryos with anencephaly, none had
aneuploidy. Of the 13 embryos with encephalocele, 11
had aneuploidy, including monosomy X (five cases),
trisomy 14 (three cases), trisomy 15 (one case), and
triploidy (two cases). Of the five embryos with classical
spina bifida, three had aneuploidy, including triploidy
(two cases) and trisomy 16 (one case). Of the 12 em-
bryos with caudal neural tube overgrowth, all had an-
euploidy, including triploidy (eight cases) and trisomy
13 (four cases). McFadden and Kalousek [3] sug-
gested that the frequency of NTDs in embryos differs
from that observed in fetuses and newborn infants.
They found that there was a predominance of enceph-
alocele and caudal NTDs in embryos. In fetuses and
newborn infants, the common observed NTDs are spina
bifida and anencephaly. Coerdt et al [4] recognized
NTDs in nine out of 91 intact first-trimester embryos
following spontaneous or induced abortion. In their
study, five of the seven NTD embryos cytogenetically
analyzed had aneuploidy, including trisomy 18 (two
spina bifidas), trisomy 7 (one encephalocele), triploidy
(one spina bifida), and monosomy X (one spina bifida).
The other two embryos (one with craniorachischisis
and one with encephalocele) were cytogenetically nor-
mal. In a study of missed abortion of 99 embryos with
a complete embryoscopic evaluation at the develop-
mental age of less than 9 weeks, Philipp and Kalousek
[5] found that 10 embryos had NTDs. All of the eight
NTD embryos cytogenetically analyzed in this study
had aneuploidy, including triploidy (two spina bifidas
and one encephalocele), trisomy 14 (one spina bifida
and one encephalocele), trisomy 9 (one anencephaly),
monosomy X (one encephalocele), and trisomy 21
(one encephalocele).
Chromosomal Abnormalities 
Associated with NTDs in Fetal and
Newborn Patients
Chromosomal abnormalities have been reported in
2.5–10.26% of fetal and newborn patients with common
NTDs [6–11]. Chromosomal abnormalities occur in
0.66–5.56% of anencephaly [6–8,10,11], 4.38–17.31%
of spina bifidas [6–8,10–14], and 2.08–12.29% of
encephaloceles [8,10,11,15]. Table 3 shows the reported
incidence of chromosomal abnormalities associated
with NTDs in fetal and newborn patients. Trisomy 18,
trisomy 13, and triploidy are the most common chro-
mosomal abnormalities associated with NTDs, and
there is a predominance of spina bifida (Table 3).
Full Aneuploidy
Numerical chromosomal abnormalities associated with
NTDs include trisomy 18, trisomy 13, triploidy, trisomy
9, trisomy 2, trisomy 21, trisomy 7, trisomy 8, trisomy 14,
trisomy 15, trisomy 16, trisomy 5 mosaicism, trisomy 11
mosaicism, trisomy 20 mosaicism, monosomy X, and
tetraploidy [16].
Trisomy 18
Trisomy 18 can be associated with spina bifida, en-
cephalocele, and anencephaly. Most of the reported
NTDs associated with trisomy 18 are spina bifidas.
Encephalocele and anencephaly have occasionally been
reported. Claussen et al [17] observed encephalocele
with mosaic trisomy 18 at 34 gestational weeks. Babini
et al [18] reported one occipital encephalocele, Menashi
et al [19] reported one anencephaly, Merrild et al [20]
reported one anencephaly, Nisani et al [21] reported
one anencephaly with cervical rachischisis, Ramos et al
[22] reported one anencephaly, Seller [23] reported
one encephalocele, Sepulveda et al [10] reported two
encephaloceles, and Chen [24] reported one anen-
cephaly in patients associated with trisomy 18. Moore
et al [25] reported craniorachischisis, large omphalo-
cele, and bilateral cleft lip and palate in a fetus with
trisomy 18. van Maldergem et al [26] reported cranio-
rachischisis, omphalocele, bilateral radial agenesis,
and distal arthrogryposis in a fetus with trisomy 18.
Grangé et al [27] reported occipital encephalocele,
craniorachischisis, and cystic hygroma in a fetus with
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trisomy 18. Donaldson et al [28] reported abdominal
wall defect of thoraco-abdominoschisis extending from
the neck to the pelvis, and craniorachischisis in a fetus
with trisomy 18. Several studies have shown that NTDs
occur in 6–11% of trisomy 18 cases [25,29,30]. Flannery
and Kahler [30] reported three meningomyeloceles
among 48 liveborn cases (6.25%) with trisomy 18.
Moore et al [25] reported 85 patients with trisomy 18
evaluated at Indiana University School of Medicine
from 1963 to 1986 and found that the frequency of
NTDs in trisomy 18 cases was 7.06% (6/85). Seller
[23], in a study of 38 mid-trimester fetuses with tri-
somy 18, found that 23.68% (9/38) had NTDs, includ-
ing eight spina bifidas and one anencephaly. Chen [24],
in a study of 89 consecutive cases of fetal trisomy 18
(mean gestational age at diagnosis: 23.5 weeks), found
that 2.25% (2/89) had NTDs, including one anen-
cephaly and one lumbosacral myelomeningocele.
Trisomy 13
Trisomy 13 can be associated with spina bifida,
encephalocele, and anencephaly. Most of the reported
NTDs associated with trisomy 13 are spina bifidas.
Encephalocele and anencephaly have occasionally been
reported. Byrne and Warburton [2] reported trisomy
13 in an aborted embryo with encephalocele. Phadke
and Thakur [31] reported prenatal diagnosis of inien-
cephaly, alobar holoprosencephaly, and cyclopia in a
fetus with mosaic trisomy 13. Halder et al [32] reported
mosaic trisomy 13 in a fetus with iniencephaly, anen-
cephaly, facial clefts, single umbilical artery, dilated
right side of the heart and club foot. Several studies
have shown that NTDs occur in about 8% of trisomy
13 cases [23,33,34]. Rodriguez et al [33] found three
spina bifidas among 34 trisomy 13 patients (8.8%).
Wyllie et al [34] found one meningocele and two en-
cephaloceles among 36 trisomy 13 patients (8.33%).
Seller [23], in a study of 25 mid-trimester trisomy 13
fetuses, found that 8% (2/25) had spina bifidas.
Triploidy
Triploidy can be associated with spina bifida, encephalo-
cele, and anencephaly. Most of the reported NTDs
associated with triploidy are spina bifidas. Several stud-
ies have shown that NTDs occur in 7–55% of triploid
embryos and 7–35% of mid-trimester triploid fetuses
[23,35–38]. Harris et al [35] found that 7.69% (2/26)
of triploid embryos had NTDs, one with iniencephaly
and thoracolumbar myelocele and the other with lum-
bosacral spina bifida. Seller [23], in a study of mid-
trimester triploid fetuses, found that 23.08% (3/13)
had spina bifidas. Jauniaux et al [36] reported five
spina bifidas among 65 cases (7.69%) with triploidy
diagnosed in the second trimester. Mittal et al [37], in
a study of 20 triploid fetuses (mean gestational age,
20.4 weeks), found that seven (35%) had open NTDs,
including six myeloceles and one encephalocele. Phillip
et al [38] found that 55.56% (10/18) of triploid
embryos had NTDs, including eight spina bifidas and
two encephaloceles.
Trisomy 9
Trisomy 9 can be associated with spina bifida and
anencephaly. Most reported NTDs associated with tri-
somy 9 are spina bifidas [8,9,39–43]. Anencephaly
associated with trisomy 9 has only been observed in
one case [5]. Phillip and Kalousek [5] reported trisomy
9 in an embryo with anencephaly at the sixth develop-
mental week. Frohlich [39] reported the prenatal diag-
nosis of trisomy 9 by amniocentesis. The fetus was
terminated at 19 weeks’ gestation, with anophthalmia,
bilateral corneal opacities, double outlet of right ven-
tricle, ventricular septal defect, left congenital diaphrag-
matic hernia and a small closed lumbar meningocele.
Benacerraf et al [40] reported the prenatal diagnosis
of trisomy 9 by amniocentesis at 31 weeks’ gestation in
a fetus with prenatal sonographic findings of intrauter-
ine growth restriction, polyhydramnios, microcephaly,
mild cerebral ventriculomegaly, ventricular septal defect,
a lumbosacral neural tube defect, clenched hands,
and club feet. The baby was delivered at 41 weeks’ ges-
tation with neonatal death and the additional findings
of cleft palate, microphthalmia, a horseshoe kidney, a
bicornuate uterus, a persistent left superior vena cava,
a dysplastic and stenotic pulmonary valve, a left uni-
lobed lung, enlarged lateral ventricles, underdeveloped
corpus callosum, right retinal dysplasia, coloboma,
and optic nerve hypoplasia. Golden and Schoene [41]
reported the prenatal diagnosis of trisomy 9 by amnio-
centesis at 33 weeks’ gestation in a fetus with a lum-
bosacral myelomeningocele, ventricular septal defect,
mild ventriculomegaly, microcephaly, rocker-bottom feet,
and clenched hands. The baby was delivered at 41
weeks’ gestation but died at age 23 days. Kennedy et al
[8] reported the prenatal diagnosis of trisomy 9 in 
a fetus with meningocele, prominent cisterna magna,
echogenic bowel, left upper quadrant calcification, sin-
gle kidney, a two-vessel cord, truncus arteriosus, single
coronary ostium, uni-lobed left lung, bi-lobed right lung,
gut malformation, micrognathia, and low-set ears. Seller
et al [42] reported a 14-week gestation abortus with a
large cystic spina bifida in the lumbosacral region and
trisomy 9. Chen et al [43] reported the prenatal diag-
nosis of trisomy 9 by amniocentesis at 19 weeks’ gesta-
tion in a fetus with intrauterine growth restriction, left
congenital diaphragmatic hernia, ascites, a horseshoe
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kidney, a small bladder, and lumbosacral spina bifida.
The fetus was terminated at 22 weeks’ gestation with
additional findings of camptodactyly and club feet.
Trisomy 2
Trisomy 2 has been described in a fetus with encephalo-
cele, spina bifida, and iniencephaly [44]. Seller et al
[44] reported the postnatal diagnosis of trisomy 2
using the tissue of umbilical cord in a 13-week gesta-
tion male fetus with an open occipital encephalocele
continuous with cervical and complete thoracic spina
bifida aperta, iniencephaly, scoliosis of the cervical
and upper thoracic spine, and kyphosis of the lower
thoracic spine. Additional findings included a central
cleft palate, fused kidneys, and left heart hypoplasia.
The mother was 41 years old. Fluorescence in situ hy-
bridization analysis of the skin confirmed trisomy 2.
The association of NTDs with trisomy 2 is likely due to
the duplication of 2p. Doray et al [45] reviewed 64
cases with partial trisomy 2p and found that 15 cases
(23.44%) had NTDs, including spina bifida, anen-
cephaly and encephalocele. Lurie et al [46] suggested
that the common triplicated region of chromosome
2p associated with NTDs is the band 2p24. Chromo-
some 2p24 contains the two genes GDF7 (growth/
differentiation factor 7) and DDEF2 (development and
differentiation enhancing factor 2) that are important
for neural tube development. GDF7 is involved in the
generation of a discrete class of commissural interneu-
rons in the spinal cord [47], and DDEF2 is involved in
cell communication and structure [48].
Trisomy 21
Trisomy 21 has occasionally been associated with spina
bifida, anencephaly, and encephalocele. Two reports
suggested no increased risk of NTDs in infants with tri-
somy 21 [49,50]. Källén et al [49], in a study of 5,581
infants with Down syndrome registered in programs of
congenital malformations in France, Italy and Sweden,
found an approximately 300 times increased risk for
annular pancreas, cataracts and duodenal atresia, an
approximately 100 times increased risk for megacolon
and choanal atresia, 10–30 times increased risks for
esophageal, anal and bowel atresia, preaxial polydactyly,
and omphalocele, 3–5 times increased risks for cleft
palate, cleft lip/palate, and limb deformities, but no
increased risks for NTDs, hydrocephaly, microtia, renal
agenesis or severe dysgenesis, and hypospadias or
polydactyly, other than preaxial polydactyly, in Down
syndrome infants. Among the 5,581 Down syndrome
infants, there were only four spina bifidas, giving an
NTD incidence of 0.72 per 1,000 infants with Down
syndrome. Torfs and Christianson [50], in a study of 
a population of close to 2.5 million infants born from
1983 to 1993 and registered in the California Birth
Defects Monitoring Program, compared the structural
birth defects among 2,894 Down syndrome infants
with that of 2,490,437 infants without Down syn-
drome and found no increased risk for NTDs in Down
syndrome infants. Among the 2,894 Down syndrome
infants, there was only one encephalocele, giving an
NTD incidence of 0.35 per 1,000 infants with Down
syndrome. Barkai et al [51] observed an increased pre-
valence of Down syndrome in the offspring of 493
mothers in Israel with an index pregnancy with NTD,
and an increased prevalence of NTD in the offspring 
of 516 mothers in Ukraine with an index pregnancy
with Down syndrome. However, recent studies did not
support the findings of Barkai et al [51] and found no
association between families at risk of NTDs and those
at risk of Down syndrome [52–54]. James et al [55]
and Hobbs et al [56] found that mothers of Down
syndrome infants have an increased frequency of com-
mon MTHFR 677C T and MTRR 66A G polymor-
phisms, and elevated levels of plasma homocysteine.
Al-Gazali et al [57] reported abnormal folate metabo-
lism and genetic polymorphism of the folate pathway
in a child with trisomy 21 and cervical meningomyelo-
cele. Molecular analysis of the MTHFR gene in that case
revealed homozygosity for the mutant 677C  T poly-
morphism in both the mother and the child. Guéant 
et al [58] suggested that both NTDs and Down syndrome
are influenced by the same genetic determinants for one-
carbon metabolism of folate, vitamin B12, and genetic
polymorphism of methylenetetrahydrofolate reductase,
methionine synthase, methionine synthase reductase
or transcobalamin. Whether folate and homocysteine
metabolism and gene polymorphism play a role in the
etiology of Down syndrome, and whether preconcep-
tion intake of folate and vitamin B12 is effective in the
prevention of Down syndrome remain unclear, and
further studies are required for verification [59,60].
Trisomy 8 and mosaic trisomy 8
Longo and Maccani [61] reported a case of myelome-
ningocele associated with trisomy 8. Mosaic trisomy 8
has been associated with spina bifida [16].
Trisomy 7
Trisomy 7 has been described at the seventh or eighth
developmental week in an embryo with encephalocele,
microcephaly, and cleft lip and palate [4].
Trisomy 14
Trisomy 14 has been described at the sixth developmen-
tal week in an embryo with encephalocele and retarded
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limb development, and at the seventh developmental
week in an embryo with spina bifida, microcephaly,
facial anomalies, and retarded limb development [5],
and in three embryos with encephalocele [3]. McDermott
and Cross [62] reported an infant with complete trisomy
14 with a de novo 13/14 translocation, thoracolumbar
meningomyelocele, horseshoe kidneys, absence of radii
and thumbs, cleft lip, a ventricular septal defect, and
neonatal death.
Trisomy 15
Trisomy 15 has been described in an embryo with
encephalocele [3].
Trisomy 16
Trisomy 16 has been described in an embryo with spina
bifida [3].
Mosaic trisomy 5
Mosaic trisomy 5 has been associated with encephalo-
cele [15].
Mosaic trisomy 11
Mosaic trisomy 11 has been associated with anen-
cephaly [16].
Mosaic trisomy 20
Mosaic trisomy 20 has been associated with encephalo-
cele [2] and anencephaly [16].
Monosomy X
Monosomy X has been described in embryos with
encephalocele [2,5]. Coerdt et al [4] reported an
embryo with spina bifida, iniencephaly, and median
cleft lip and palate at the sixth developmental week.
Kennedy et al [8] reported a fetus with the karyotype
of 45,X and abnormal sonographic findings of lum-
bosacral meningocele and Arnold-Chiari malformation.
Halder et al [32] reported mosaic monosomy X in a
fetus with iniencephaly, cystic hygroma, congenital
diaphragmatic hernia, and hydrops fetalis. Monosomy
X is the single most common aneuploidy in sponta-
neous abortion. Philipp and Kalousek [63] found that
24 out of 108 (22.22%) embryos in missed abortions had
monosomy X. However, only a single case of enceph-
alocele could be observed among the 24 monosomy 
X embryos.
Tetraploidy
Tetraploidy has been described in infants with spina
bifida [64–66]. Pitt et al [64] reported a 15-day-old
tetraploid (92,XXYY) infant born to a 27-year-old mother.
The infant manifested facial dysmorphism, positional
limb defects, urinary tract abnormalities, hydrocephalus,
and sacral meningomyelocele. Scarbrough et al [65]
reported a small-for-date tetraploid (92,XXXX) infant
born to a 19-year-old mother. The infant manifested
hypotonia, scaphocephaly, bilateral anophthalmia, facial
dysmorphism, a lumbosacral meningomyelocele, arachn-
odactyly, craniosynostosis, Arnold-Chiari malformation,
and cerebellar hypoplasia and died at 2 days of age.
Shiono et al [66] reported a 15-month-old tetraploid
(92,XXXX) infant born to a 35-year-old mother. The
infant manifested micro-turricephaly, a prominent but
narrow forehead, microphthalmia or anophthalmia,
limb anomaly, sacral meningomyelocele, and mental
retardation.
Conclusion
This article provides an overview of chromosomal ab-
normalities associated with NTDs in embryos, fetuses,
and newborn patients, and a comprehensive review of
numerical chromosomal abnormalities associated with
NTDs, such as trisomy 18, trisomy 13, triploidy, tri-
somy 9, trisomy 2, trisomy 21, trisomy 7, trisomy 8, tri-
somy 14, trisomy 15, trisomy 16, trisomy 5 mosaicism,
trisomy 11 mosaicism, trisomy 20 mosaicism, mono-
somy X, and tetraploidy. NTDs may be associated with
aneuploidy. Perinatal identification of NTDs should
alert one to the possibility of chromosomal abnormal-
ities and prompt a thorough cytogenetic investigation
and genetic counseling.
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